Citius Pharmaceuticals, Inc. (CTXR)

NASDAQ: CTXR · Real-Time Price · USD

0.7706

-0.0418 (-5.15%)

At close: Mar 20, 2026, 4:00 PM EDT

0.7860

+0.0154 (2.00%)

After-hours: Mar 20, 2026, 6:37 PM EDT

Citius Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar '26 Mar 20, 2026	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021	Sep '20 Sep 30, 2020
Market Cap	17	91	109	177	296	58
Market Cap Growth	12.70%	-16.54%	-38.55%	-40.30%	412.69%	163.71%
Enterprise Value	11.35	91.77	83.32	136.48	227.72	45.29
Last Close Price	0.77	12.52	17.11	30.25	50.75	26.00
PE Ratio	-	-2.10	-3.07	-5.26	-8.83	-2.31
Forward PE	0.40	8.71	-	-	7.88	-
PB Ratio	0.22	1.29	1.20	1.72	2.24	1.72
P/TBV Ratio	0.10	1.20	1.14	1.72	1.67	1.21
P/FCF Ratio	-	-3.22	-3.74	-6.24	-12.22	-3.41
P/OCF Ratio	-	-3.22	-3.74	-6.24	-12.22	-3.41
EV/EBITDA Ratio	-	-2.20	-2.28	-4.12	-9.75	-2.58
EV/EBIT Ratio	-	-2.19	-2.27	-4.10	-9.68	-2.56
EV/FCF Ratio	-	-3.25	-2.87	-4.81	-9.39	-2.67
Debt / Equity Ratio	0.03	0.00	0.01	0.01	0.01	0.04
Debt / EBITDA Ratio	-0.05	-0.01	-0.01	-0.02	-0.04	-0.08
Debt / FCF Ratio	-0.09	-0.01	-0.02	-0.02	-0.04	-0.08
Quick Ratio	0.12	0.09	4.58	9.21	17.60	3.38
Current Ratio	0.47	0.40	5.95	9.84	18.28	3.41
Return on Equity (ROE)	-61.66%	-47.63%	-33.40%	-28.48%	-27.70%	-57.70%
Return on Assets (ROA)	-33.88%	-38.70%	-34.37%	-26.44%	-25.28%	-43.99%
Return on Invested Capital (ROIC)	-41.52%	-47.94%	-53.60%	-49.66%	-49.70%	-70.05%
Return on Capital Employed (ROCE)	-54.23%	-47.01%	-35.44%	-26.88%	-26.42%	-49.32%
Earnings Yield	-208.12%	-47.68%	-32.55%	-19.01%	-11.33%	-43.27%
FCF Yield	-202.02%	-31.08%	-26.73%	-16.03%	-8.19%	-29.29%
Buyback Yield / Dilution	-	-15.21%	-12.72%	0.00%	-40.71%	-39.33%

Updated Dec 23, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q